Kelly Flook, Ph.D. is a Senior Manager within the bioproduction product management team at Thermo Fisher Scientific, where she leads strategy and development for advanced analytical technologies supporting bioprocessing workflows. With more than 20 years of experience in chromatography and bioseparation, Kelly specializes in scalable solutions for complex biologics, including monoclonal antibody-based therapeutics and next-generation vaccines.

Kelly holds a Ph.D. in Polymer and Analytical Chemistry from the University of Durham, UK. Throughout her career, she has combined deep technical expertise with commercial insight to bring innovative technologies from concept to global launch. Her work focuses on enabling biopharma partners to accelerate process development, improve manufacturing efficiency, and deliver life-changing therapies to patients worldwide.

She is a frequent contributor to industry publications and conferences, where she speaks on various challenges, emerging modalities, and the future of pharma analytics innovation.